U.S.-based investment fund Mason Capital said on Monday it had sent a letter to Spain's stock market regulator CNMV demanding ...
Grifols said it plans to outline its strategy ... takeover bid. The Spanish pharmaceutical company said late Wednesday that it would soon schedule an investor update at which it would present ...
Canadian fund Brookfield said it had dropped its plan to take over Spain’s Grifols due to a disagreement over the pharmaceutical company’s value, while Grifols said it ...
The family that owns Spanish drugmaker Grifols ... The company, first formed in 1909 and headquartered in Barcelona, is a manufacturer of plasma-based pharmaceuticals and other products like ...
Grifols, a global healthcare company and leading producer of plasma-derived medicines, today announced it has received a grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) to ...
Spanish pharma Grifols is leveraging its massive collection ... will be spearheaded by Grifols’ subsidiary Alkahest, the company said in a Jan. 14 release. The MJFF’s funds will power a ...
Private equity company Brookfield has reportedly moved closer to taking control of Grifols, after months of disruption at the Spanish pharma company. A report in Spanish newspaper El Confidencial ...
Canadian fund Brookfield said it had dropped its plan to take over Spain’s Grifols due to a disagreement over the pharmaceutical company’s value, while Grifols said it concurred with the ...
But it can only be used by Brookfield, or a Brookfield-led group as the buyer of the company, according to people familiar with the deal. Brookfield’s pursuit of Grifols formally ended two weeks ...
Mason Capital Management LLC’s Kenneth M Garschina has called the Spanish regulator’s attention to Grifols SA’s “severe lack of disclosure” as he tries to push for a board reshuffle.
The American investment company Brandes Investment Partners LP has acquired a stake in the Spanish pharmaceutical company Grifols SA amid plans by Canadian Brookfield Asset Management to acquire ...
U.S.-based investment fund Mason Capital said on Monday it had sent a letter to Spain's stock market regulator CNMV demanding more transparency from the embattled pharmaceutical company Grifols ...